{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-030718","form_type":"8-K","ticker":"RCKT","cik":"0001281895","company_name":"ROCKET PHARMACEUTICALS, INC.","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.700748+00:00","generated_at":"2026-06-01T03:15:13.223455+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Rocket Pharma increases authorized shares to 180M after shareholder approval","bullets":["Authorized common shares increased from 120M to 180M (50% increase); amendment effective June 20, 2024.","All ten director nominees elected; highest vote totals over 71M 'for' votes.","Ratification of EisnerAmper as independent auditor for FY 2024 approved by ~99.9% of votes cast.","Non-binding advisory vote on named executive officer compensation passed with ~98.4% of votes cast.","Voter turnout approximately 87.95% of outstanding shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-030718","json":"https://secwatch.observer/filing/0001140361-24-030718.json","markdown":"https://secwatch.observer/filing/0001140361-24-030718.md","text":"https://secwatch.observer/filing/0001140361-24-030718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124030718/0001140361-24-030718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124030718/ef20031374_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:15:13.223455+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}